1 |
Brayden, J. E. Potassium channels in vascular smooth muscle. Clin. Exp. Pharmacol. Physiol. 1996, 23, 1069-1076
|
2 |
Glusa, E. and Pertz, H. H. Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B) receptors. Br. J. Pharmacol. 2000, 130, 692-698
|
3 |
Jagadesh, S. R. and Subhash, M. N. Effect of antidepressants on intracellular mobilization in human frontal cortex. Biol. Psychiatery. 1998, 44, 617-621
|
4 |
Tuladhar, B. R., Costall, B. and Naylor, R. J. Pharmacological characterization of the 5-hydroxytryptamine receptor mediating relaxation in the rat isolated ileum. Br. J. Pharmacol. 1996, 119, 303-310
|
5 |
Li, Q., Brownfield, M. S., Battaglia, G., Cabrera, T. M., Levy, A. D., Rittenhouse, P. A. and van de Kar, L. D. Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI). J. Pharmacol. Exp. Ther. 1993, 266, 836-844
|
6 |
Ni, Y. G. and Miledi, R. Blockage of 5- serotonin receptors by fluoxetine (Prozac). Proc. Natl. Acad. Sci. USA. 1997, 94, 2036-2040
|
7 |
Somlyo, A. P. and Himpens, B. Cell calcium and its regulation in smooth muscle. FASEB J. 1989, 3, 2266-2276
|
8 |
Nakajima, T., Hazama, H., Hamada, E., Wu, S. N., Igarashi, K., Yamashita, T., Seyama, Y., Omata, M. and Kurachi, Y. Endothelin-1 and vasopressin activate Ca(2+)-permeable non-selective cation channels in aortic smooth muscle cells: mechanism of receptormediated influx. J. Mol. Cell Cardiol. 1996, 28, 707-722
|
9 |
Lavoie, P. A., Beauchamp, G. and Elie, R. Atypical antidepressants inhibit depolarization-induced calcium uptake in rat hippocampus synaptosomes. Can. J. Physiol. Pharmacol. 1997, 75, 983-987
|
10 |
Villazon, M., Padin, J. F., Cadavid, M. I., Enguix, M, J., Tristan, H., Orallo, F. and Loza, M. I. Functional characterization of serotonin receptors in rat isolated aorta. Biol. Pharm. Bull. 2002, 25, 584-590
|
11 |
Terron, J. A. Antagonism of the relaxant 5-HT receptor in the dog basilar artery by the high-affinity 5- receptor ligand, LY215840. Proc. West Pharmacol. Soc. 1998, 41, 129-130
|
12 |
Ellis, E. S., Byrne, C., Murphy, O. E., Tilford, N. S. and Baxter, G. S. Mediation by 5-hydroxytryptamine 2B receptors of endothelium-dependent relaxation in rat jugular vein. Br. J. Pharmacol. 1995, 114, 400-404
|
13 |
Busch, L., Wald, M., Sterin-Borda, L. and Borda, E. Fluoxetine modulates norepinephrine contractile effect on rat vas deferens. Pharmacol. Res. 2000, 41, 39-45
|
14 |
Huang, Y. Inhibitory effect of noradrenalin uptake inhibitors on contractions of rat aortic smooth muscle. Br. J. Pharmacol. 1996, 117, 533-539
|
15 |
Pitt, B. R., Weng, W., Steve, A. R., Blakely, R. D., Reynolds, I. and Davies, P. Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. Am. J. Physiol. 1994, 266, L178-186
|
16 |
Carvajal, J. A., Germain, A. M., Huidobro-Toro, J. P. and Weiner, C. P. Molecular mechanism of cGMPmediated smooth muscle relaxation. J. Cell Physiol. 2000, 184, 409-420
|
17 |
Pacher, P., Ungvari, Z., Kecskemeti, V. and Koller, A. Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered sensitivity. Br. J. Pharmacol. 1999, 127, 740-746
|
18 |
Terron, J. A. and Falcon-Neri, A. Pharmacological evidence for the 5- receptor mediating smooth muscle relaxation in canine cerebral arteries. Br. J. Pharmacol. 1999, 127, 609-616
|
19 |
Reeves, J. J., Bunce, K. T. and Humphrey, P. P. Investigation into the 5-hydroxytryptamine receptor mediating smooth muscle relaxation in the rat oesophagus. Br. J. Pharmacol. 1991, 103, 1067-1072
|
20 |
Velasco, A., Alamo, C., Hervas, J. and Carvajal, A. Effects of fluoxetine hydrochloride and fluvoxamine maleate on different preparations of isolated guinea pig and rat organ tissues. Gen. Pharmacol. 1997, 28, 509-512
|
21 |
Hudgins, P. M. and Weiss, G. B. Differential effects of calcium removal upon vascular smooth muscle contraction induced by norepinephrine, histamine and potassium. J. Pharmacol. Exp. Ther. 1968, 159, 91-97
|
22 |
Pacher, P., Ungvari, Z., Kecskemeti, V., Friedmann, T. and Furst, S. Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle. Can. J. Physiol. Pharmacol. 2001, 79, 580-584
|
23 |
Karaki, H., Ozaki, H., Hori, M., Mitsui-Saito, M., Amano, K., Harada, K., Miyamoto, S., Nakazawa, H., Won, K. J. and Sato, K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev. 1997, 49, 157-230
|
24 |
Ungvari, Z., Pacher, P., Kecskemeti, V. and Koller, A. Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca(2+) channel opener. Stroke. 1999, 30, 1949-1954
|
25 |
Lucchelli, A., Santagostino-Barbone, M. G., Masoero, E., Baiardi, P. and Tonini, M. Influence of fluoxetine and litoxetine on 5- receptor-mediated relaxation in the rat isolated oesophagus. Fundam. Clin. Pharmacol. 1999, 13, 330-336
|
26 |
Taggart, M. J., Menice, C. B., Morgan, K. G. and Wray, S. Effect of metabolic inhibition on intracellular , phosphorylation of myosin regulatory light chain and force in rat smooth muscle. J. Physiol. 1997, 499, 485-496
|
27 |
Fernandez del Pozo, B., Perez-Vizcaino, F., Fernandez, C., Zaragoza, F. and Tamargo, J. Effects of several class I antiarrhythmic drugs on isolated rat aortic vascular smooth muscle. Gen. Pharmacol. 1997, 29, 539-543
|
28 |
Leung, E., Walsh, L. K., Pulido-Rios, M. T. and Eglen, R. M. Characterization of putative 5- receptors mediating direct relaxation in Cynomolgus monkey isolated jugular vein. Br. J. Pharmacol. 1996, 117, 926-930
|
29 |
Ungvari, Z., Pacher, P. and Koller, A. Serotonin reuptake inhibitor fluoxetine decreases arteriolar myogenic tone by reducing smooth muscle [ ]i. J. Cardiovasc. Pharmacol. 2000, 35, 849-854
|
30 |
Cauvin, C., Loutzenhiser, R. and van Breemen, C. Mechanism of calcium-antagonist induced vasodilation. Annu. Rev. Pharmacol. 1983, 23, 373-396
|
31 |
Vila, J. M., Medina, P., Segarra, G., Lluch, P., Pallardo, F., Flor, B. and Lluch, S. Relaxant effects of antidepressants on human isolated mesenteric arteries. Br. J. Clin. Pharmacol. 1999, 48, 223-229
|
32 |
Pancrazio, J. J., Kamatchi, G. L., Roscoe, A. K. and Lynch, C. 3rd. Inhibition of neuronal channels by antidepressant drugs. J. Pharmacol. Exp. Ther. 1998, 284, 208-214
|
33 |
Tytgat, J., Maertens, C. and Daenens, P. Effect of fluoxetine on a neuronal voltage-dependent potassium channel. Br. J. Pharmacol. 1997, 122. 1417-1424
|
34 |
Garcia-Colunga, J., Awad, J. N. and Miledi, R. Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac). Proc. Natl. Acad. Sci. USA. 1997, 94, 2041-2044
|
35 |
McLean, P. G. and Coupar, I. M. Characterisation of a postjunctional 5- -like and a prejunctional 5- receptor mediating contraction of rat isolated jejunum. Eur. J. Pharmacol. 1996, 312, 215-225
|